United States
-
TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition
– Posters highlight discovery of TSC-101, manufacturing process and clinical development plan for liquid tumor candidates TSC-101 and TSC-102 – – Phase 1 clinical trial expected to initiate in the first half of 2021 – – Company…
Read More »